Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia
Authors:
- Misako HamamuraMHMisako Hamamura
- Tomoaki KuwanoTKTomoaki Kuwano
- Hiroshi NagataHNHiroshi Nagata
- Takamasa HashimotoTHTakamasa Hashimoto
- Atsushi OgawaAOAtsushi Ogawa
- Naohisa UchimuraNUNaohisa Uchimura
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 12 (2) , 127-133
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceutical Company
This publication has 15 references indexed in Scilit:
- Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomniaSleep Medicine, 2011
- Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary InsomniaThe Journal of Clinical Psychiatry, 2009
- Effects of long‐term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomniaHuman Psychopharmacology: Clinical and Experimental, 2008
- A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomniaCurrent Medical Research and Opinion, 2007
- Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Medicine, 2006
- An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomniaSleep Medicine, 2006
- Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefitsBMJ, 2005
- Chronic InsomniaNew England Journal of Medicine, 2005
- Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonistNeuropharmacology, 2005
- Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretionEuropean Neuropsychopharmacology, 1996